Innate Pharma (IPHA) Shares Outstanding (Entity) (2017 - 2025)
Innate Pharma (IPHA) Shares Outstanding (Entity) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.94 Bn | 132.09 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 86.59 Bn | 78.60 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 65.67 Bn | 60.49 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 57.81 Bn | 52.67 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 42.25 Bn | 37.15 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.76 Bn | 28.45 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 28.41 Bn | 10.02 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 575.47 Mn |
| 10 | Innate Pharma | 204.72 Mn | 204.72 Mn | - | 93.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 90.00 |
| Jun 30, 2025 | 87.00 |
| Dec 31, 2024 | 81.00 |
| Jun 30, 2024 | 81.00 |
| Dec 31, 2023 | 80.00 |
| Jun 30, 2023 | 80.00 |
| Dec 31, 2022 | 80.00 |
| Jun 30, 2022 | 80.00 |
| Dec 31, 2021 | 80.00 |
| Jun 30, 2021 | 79.00 |
| Dec 31, 2020 | 79.00 |
| Jun 30, 2020 | 79.00 |
| Dec 31, 2019 | 67.00 |
| Jun 30, 2019 | 64.00 |
| Dec 31, 2018 | 59.00 |
| Dec 31, 2017 | 54.00 |